Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2025-01-01T00:02:58.046Z Has data issue: false hasContentIssue false
  • English
  • Français

Clostridium difficile and Sucralfate

Published online by Cambridge University Press:  02 January 2015

Gordon Jensen  and
James E. Bross
Gordon Jensen
Affiliation:
Geisinger Clinic Danville, Pennsylvania
James E. Bross
Affiliation:
Geisinger Clinic Danville, Pennsylvania
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 17 , Issue 11 , November 1996 , pp. 712 - 713
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1996

References

REFERENCES

1. Jensen, GL, Bross, JE, Bourbeau, PP, Naumowitz, DW, Streater, M, Gianferante, LE. Risk factors for Clostridium difficile stool cytotoxin b among critically ill patients; role of sucralfate. J Infect Dis 1994;170:227–230.CrossRefGoogle ScholarPubMed
2. Watanakunakorn, PW, Watanakunakorn, C, Hazy, J. Risk factors associated with Clostridium difficile diarrhea in hospitalized adult patients: a case-control study—sucral-fate ingestion is not a negative risk factor. Infect Control Hosp Epidemiol 1996;17:232–235.Google Scholar
3. Lichtenstein, MJ, Mulrow, CD, Elwood, PC. Guidelines for reading case-control studies. J Chronic Dis 1987;40:893–903.Google Scholar
4. Wacholder, S, McLaughlin, JK, Silmerman, DJ, Mandel, JS. Selection of controls in case-control studies: 1, principles. Am J Epidemiol 1992;135:1019–1040.Google Scholar
5. Naumowitz, D, Bourbeau, P, Jensen, G, Bross, J. In vitro inhibition of Clostridium difficile cytotoxin B assay by sucralfate. In: Abstracts from the 32nd Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy; 09 1992; Chicago, IL. Abstract 1250.Google Scholar